As the legalization of medical cannabis advances, the 2024 Cannabis Barometer from Bloomwell reveals critical insights into the cannabis landscape in Germany. The survey, which involved over 1,000 participants, shows that although 94.4% of respondents use cannabis for health reasons, nearly 60% still resort to illegal sources. Additionally, social stigma and limited access to cannabis-trained doctors remain significant barriers. Despite regulatory improvements, patients continue to face challenges in obtaining safe and legal cannabis.
The State of Cannabis in Germany: Key Findings from the 2024 Survey:
Widespread Use for Medical Purposes A staggering 94.4% of respondents reported using cannabis to address health concerns such as chronic pain, stress, and sleep disorders. This underscores the importance of cannabis as a therapeutic option, with many users seeking to reduce reliance on traditional pharmaceuticals. For instance, 20% of patients reported being able to reduce or eliminate other medications due to cannabis use.
Continued Reliance on Illegal Sources Despite legal advances, the majority of cannabis users still purchase from illegal markets, citing cost barriers and difficulties in accessing medical cannabis. Only 10% of participants obtained cannabis solely through legal channels, and more than 26% had purchased contaminated or low-quality cannabis on the black market, raising serious health concerns.
Stigma and Misunderstanding Many respondents feel socially stigmatized due to their cannabis use, with 77% reporting negative societal attitudes. This stigma contributes to the persistence of illegal cannabis use, as patients fear being judged by healthcare providers and society. Interestingly, the survey dispels the notion that cannabis is primarily used by men; women accounted for 41% of users.
Telemedicine as a Solution Access to cannabis-friendly doctors remains a hurdle, with 92% of respondents supporting the use of telemedicine as a safer, more convenient way to receive treatment. The demand for digital health services has skyrocketed, with patients eager for a streamlined process of receiving prescriptions and delivery from pharmacies.
Regional and Demographic Trends The survey highlighted regional variations in cannabis use, with North Rhine-Westphalia and Bavaria showing the highest rates of consumption. Additionally, the data revealed that cannabis use is not restricted to younger people; 28% of users were between the ages of 31-40, and another 28% were aged 22-30.
Challenges in Accessing Legal Cannabis
Germany’s medical cannabis system, despite legal improvements, has failed to keep pace with patient demand. A significant portion of patients are still without access to physicians knowledgeable in cannabis therapies, forcing many to turn to illegal sources. This gap in healthcare is further exacerbated by doctors’ reluctance to prescribe cannabis due to lingering stigmas and a lack of education about its medical uses.
Patients who rely on medical cannabis also face economic barriers. The survey revealed that a large number of users simply cannot afford the high cost of legally prescribed cannabis, which is often not fully covered by insurance. This drives many to the black market, despite concerns over quality and safety.
Cannabis in Germany 2024
Addressing Stigma and Misinformation
Stigma remains one of the largest hurdles for medical cannabis patients in Germany. According to the survey, 77% of patients feel judged by society for their cannabis use, even though the vast majority use it for legitimate medical reasons. This negative perception often prevents patients from discussing their cannabis use with doctors, which can lead to unsafe consumption practices or ineffective treatment plans.
Addressing stigma will require a multi-faceted approach, including public education campaigns to inform the public about the legitimate medical uses of cannabis and its potential to improve quality of life. The medical community also needs to be more proactive in normalizing cannabis treatments, offering patients a stigma-free environment to discuss their needs.
The Growing Role of Telemedicine
Telemedicine presents a promising solution to many of the access issues facing medical cannabis patients in Germany. With 92% of respondents supporting telemedicine for cannabis prescriptions, there is a clear demand for more flexible, patient-friendly healthcare solutions. Telemedicine can bridge the gap for those living in areas where cannabis-friendly doctors are scarce, offering consultations and prescriptions through digital platforms.
Moreover, telemedicine aligns with the modern patient’s preference for convenience and privacy, making it an attractive option for those seeking cannabis treatments without the fear of social judgment.
Policy Recommendations and the Path Forward
The Cannabis Barometer data highlights several key areas where policy improvements are needed:
Increase Education for Healthcare Providers: More doctors need comprehensive training on cannabis therapies to better meet the growing demand. This will reduce the number of patients turning to illegal sources.
Tackle Stigma through Public Campaigns: Education campaigns targeting both the public and the medical community can help reduce the stigma surrounding cannabis use, encouraging safer and more transparent patient-doctor communication.
Improve Access through Telemedicine: Telemedicine should be further integrated into the healthcare system, especially in rural areas where access to cannabis-friendly physicians is limited.
Ensure Affordability of Legal Cannabis: Financial barriers to accessing medical cannabis need to be addressed, possibly through better insurance coverage or government subsidies to prevent patients from resorting to the black market.
Conclusion
The 2024 Cannabis Barometer survey sheds light on the complex landscape of medical cannabis use in Germany. While legalization has paved the way for improved access, significant barriers remain in the form of stigma, high costs, and limited healthcare access. Addressing these issues through policy reform, public education, and expanding telemedicine will be crucial in ensuring that cannabis can be safely and effectively used by the people who need it most.
States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.
The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.
“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”
Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.
States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.
In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.
Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.
The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.
This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.
The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.
The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.
The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.
Photo by yavdat/Getty Images
The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.
Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.
In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.
This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.
Not everyone has access to marijuana to help them sleep – good news, hemp is available.
it’s estimated 50 to 70 million Canadian and American adults experience sleep disorders or disturbances, and about one-third of adults don’t regularly get the recommended amount. Hemp has emerged as a promising natural remedy for those seeking better sleep. With its calming properties and potential to address various sleep-related issues, hemp-derived products are gaining popularity among individuals looking to improve their rest. Here is how hemp helps you sleep.
Hemp contains several compounds contributing to better sleep quality. Cannabidiol (CBD), a non-psychoactive component of hemp, has shown potential in promoting relaxation and reducing anxiety, which can often interfere with a good night’s rest. Studies suggest that CBD may help individuals fall asleep faster and experience fewer sleep disturbances throughout the night.
When formulated and used properly, preliminary research and user reports suggest that hemp gummies improve subjective sleep quality. Users of quality hemp sleep gummies report feeling more rested, a better quality of sleep and fewer awakenings in the night. However, clinical research has shown that over consumption of THC negatively impacts the quality of sleep, especially with long term use.
Wana Brands has launched a hemp sleeping product nationally, Mike Hennesy, Vice President of Innovation shared the following about how it works. Naturally hemp-derived sleep gummies contain the same cannabinoids like CBD, CBN, and THC as cannabis or marijuana. These ingredients interact with receptors in the body’s endocannabinoid system, which plays a role in regulating mood, stress, and sleep-wake cycles. For example, CBD may promote relaxation and reduce anxiety, CBN can relieve discomfort and reduce awakenings, while THC can shorten the time it takes to fall asleep, especially at low doses. Together, they may help ease the mind and body into a sleep-ready state.
The best sleep products don’t rely on just one cannabinoid like CBN but instead use a combination of cannabinoids, terpenes, and other sleep-supporting ingredients such as melatonin. This is because the reasons for sleeplessness are multifaceted, and include trouble falling asleep, staying asleep, chronic, pain and anxiety. Each ingredient targets different root causes as well as synergizes with the other cannabinoids and terpenes for the best night sleep.
Longer lasting formulations can actually help reduce awakenings in the night. CBN has been shown in recent research to reduce the number of times you wake up in the night. Combined with other cannabinoids they can synergize to reduce discomfort and anxiety helping consumers stay asleep.
If you do wake up in the middle of the night and can’t fall back asleep products including CBD and CBG to reduce middle of the night anxiety and racing thoughts that can keep us awake, and they have only 1mg of THC so you wake up refreshed and not high in the morning.
For most people, hemp-derived cannabinoids are considered safe and non-intoxicating, with a low risk of dependence. When THC is included in small amounts, it can produce mild effects and can help us fall asleep faster. It generally poses a minimal risk when used in moderation, but there is a potential for dependence if overused, just like with any sleep aid. Adverse events are far more prevalent in pharmaceutical and even over the counter sleep aids than with hemp-derived cannabinoids.
The key is responsible use, including starting with a low dose and taking breaks when needed. If you rely on it every night at high doses, your body may adjust, and it can be habitual. But when used in moderation and with a well-balanced formula, cannabis can be a sustainable part of a healthy sleep routine.